Clustering of two fragile sites and seven homeobox genes in human chromosome region 2q31→q32.1 (original) (raw)
Article navigation
2000
This article was originally published in
Cytogenetics and Cell Genetics
Research Articles| October 06 2000
Dipartimento di Genetica e Biologia Molecolare, Università La Sapienza, Roma (Italia)
Search for other works by this author on:
Dipartimento di Genetica e Biologia Molecolare, Università La Sapienza, Roma (Italia)
Search for other works by this author on:
Dipartimento di Genetica e Biologia Molecolare, Università La Sapienza, Roma (Italia)
Search for other works by this author on:
Dipartimento di Genetica e Biologia Molecolare, Università La Sapienza, Roma (Italia)
Search for other works by this author on:
Cytogenetics and Cell Genetics (2000) 90 (1-2): 151–153.
Abstract
In this study we have used FISH to examine the relationship between a group of homeobox genes, namely DLX1/DLX2, EVX2 and four HOXD genes (10, 11, 12, 13), that map to region q31 on chromosome 2, and the FRA2G and FRA2H fragile sites located at 2q31 and 2q32.1 respectively. Our results indicate that these homeobox genes lie between the two fragile regions.
References
Cillo C, Faiella A, Cantile M, Boncinelli E: Homeobox genes and cancer. Exp Cell Res 248:1–9 (1999).
D’Esposito M, Morelli F, Acampora D, Migliaccio E, Simeone A, Boncinelli E: EVX2, a human homeobox gene homologous to the even-skipped segmentation gene, is localized at the 5′ end of HOX4 locus on chromosome 2. Genomics 10:43–50 (1991).
Glover TW, Berger C, Coyle J, Echo B: DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67:136–142 (1984).
Limongi MZ, Pelliccia F, Rocchi A: Assignment of the human nebulin gene (NEB) to chromosome band 2q24.2 and the α1 (III) collagen gene (COL3A1) to chromosome band 2q32.2 by in situ hybridization; the FRA2G common fragile site lies between the two genes in the 2q31 band. Cytogenet Cell Genet 77:259–260 (1997).
Mitelman F, Mertens F, Johansson: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet 15:417–474 (1997).
Rocchi A, Pelliccia F: Synergistic effect of DAPI and thymidylate stress conditions on the induction of common fragile sites. Cytogenet Cell Genet 48:51–54 (1988).
Rossi E, Faiella A, Zeviani M, Labeit S, Floridia G, Brunelli S, Cammarata M, Boncinelli E, Zuffardi O: Order of six loci at 2q24→q31 and orientation of the HOXD locus. Genomics 24:34–40 (1994).
Simeone A, Acampora D, Pannese M, D’Esposito M, Stornaiuolo A, Gulisano M, Mallacci A, Kastury K, Druck T, Huebner K, Boncinelli E: Cloning and characterization of two members of the vertebrate Dlx gene family. Proc natl Acad Sci, USA 91:2250–2254 (1994).
Smith DI, Huang H, Wang L: Common fragile sites and cancer (review). Int J Oncol 12:187–196 (1998).
Stuart TD, Yokota Y, Gruss P: PAX and HOX in neoplasia. Adv Genet 33:255–274 (1995).
Yunis JJ, Soreng AL, Bowe AE: Fragile sites are targets of diverse mutagens and carcinogens. Oncogene1:59–69 (1987).
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental
This article is also available for rental through DeepDyve. 